Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.
Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, Riley WA, Shear CL, Duggan WT, Bots ML; RADIANCE 1 Investigators. Kastelein JJ, et al. Among authors: van leuven si. N Engl J Med. 2007 Apr 19;356(16):1620-30. doi: 10.1056/NEJMoa071359. Epub 2007 Mar 26. N Engl J Med. 2007. PMID: 17387131 Free article. Clinical Trial.
Atorvastatin.
van Leuven SI, Kastelein JJ. van Leuven SI, et al. Expert Opin Pharmacother. 2005 Jun;6(7):1191-203. doi: 10.1517/14656566.6.7.1191. Expert Opin Pharmacother. 2005. PMID: 15957972 Review.
High-density lipoprotein: a fall from grace?
van Leuven SI, Stroes ES, Kastelein JJ. van Leuven SI, et al. Ann Med. 2008;40(8):584-93. doi: 10.1080/07853890802082104. Ann Med. 2008. PMID: 18608128 Free article. Review.
Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials.
Vergeer M, Bots ML, van Leuven SI, Basart DC, Sijbrands EJ, Evans GW, Grobbee DE, Visseren FL, Stalenhoef AF, Stroes ES, Kastelein JJ. Vergeer M, et al. Among authors: van leuven si. Circulation. 2008 Dec 9;118(24):2515-22. doi: 10.1161/CIRCULATIONAHA.108.772665. Epub 2008 Nov 24. Circulation. 2008. PMID: 19029469 Clinical Trial.
High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans.
Birjmohun RS, van Leuven SI, Levels JH, van 't Veer C, Kuivenhoven JA, Meijers JC, Levi M, Kastelein JJ, van der Poll T, Stroes ES. Birjmohun RS, et al. Among authors: van leuven si, van t veer c, van der poll t. Arterioscler Thromb Vasc Biol. 2007 May;27(5):1153-8. doi: 10.1161/ATVBAHA.106.136325. Epub 2007 Feb 15. Arterioscler Thromb Vasc Biol. 2007. PMID: 17303780
44 results